Equity Analysis /
United States of America

US : Global Blood Therapeutics, Inc. - GBT | Highlights From Meeting With Management & Model Updates

    Daniil Gataulin
    Daniil Gataulin

    Ph.D., Sr. Res. Assoc.

    19 January 2021
    Published byCGS-CIMB

    We caught up with the GBT team last week to talk about Oxbryta launch dynamics and plans for pipeline advancement in 2021. We adjusted our model to better reflect impact of COVID related headwinds which are currently expected through 1H21, and a ramp in OpEx spend over the course of the year. While